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Background: Chlorpyrifos (CPF) is one of the most widely used organophosphate pesticides worldwide.
Epidemiological studies on pregnant women and their children suggest a link between in utero CPF exposure and
delay in psychomotor and cognitive maturation. A large number of studies in animal models have shown adverse
effects of CPF on developing brain and more recently on endocrine targets. Our aim was to determine if
developmental exposure to CPF affects social responsiveness and associated molecular neuroendocrine markers at
adulthood.
Method: Pregnant CD1 outbred mice were fed from gestational day 15 to lactation day 14 with either a
CPF-added (equivalent to 6 mg/kg/bw/day during pregnancy) or a standard diet. We then assessed in the offspring
the long-term effects of CPF exposure on locomotion, social recognition performances and gene expression levels
of selected neurondocrine markers in amygdala and hypothalamus.
Results: No sign of CPF systemic toxicity was detected. CPF induced behavioral alterations in adult offspring of
both sexes: CPF-exposed males displayed enhanced investigative response to unfamiliar social stimuli, whereas
CPF-exposed females showed a delayed onset of social investigation and lack of reaction to social novelty. In parallel,
molecular effects of CPF were sex dimorphic: in males CPF increased expression of estrogen receptor beta in
hypothalamus and decreased oxytocin expression in amygdala; CPF increased vasopressin 1a receptor expression
in amygdala in both sexes.
Conclusions: These data indicate that developmental CPF affects mouse social behavior and interferes with
development of sex-dimorphic neuroendocrine pathways with potential disruptive effects on neuroendocrine axes
homeostasis. The route of exposure selected in our study corresponds to relevant human exposure scenarios, our
data thus supports the view that neuroendocrine effects, especially in susceptible time windows, should deserve
more attention in risk assessment of OP insecticides.
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An increasing body of data collected in the past decade
supports the developmental neurotoxicity of organo-
phosphate insecticides (OPs), and of the most widely ap-
plied of them, chlorpyrifos (CPF), in particular. Most
non-agricultural uses of CPF such as residential control
of insect pests were phased out in the United States in
2001 [1] and in the European Union (EU) in 2005 [2].
Meanwhile, CPF remains by far the most used OP in-
secticide in agriculture in US and Europe today [3] and
exposure of pregnant women, infants, and children in
the general population to CPF is ubiquitous and occurs
primarily through the diet [4].
Several epidemiological studies indicate that develop-
mental OP exposure may affect children’s neuropsycho-
logical maturation [5]. In a New York newborn cohort,
in utero exposure to CPF from household use induced
delays in cognitive and psychomotor development [6]
and these effects were not influenced by socio-economic
factors [7]. Very low concentrations of CPF in cord
blood were associated with 1.4% decrease of child’s IQ
and 2.8% decrement of working memory [8], an effect
more evident in males [9]. Significant associations be-
tween prenatal CPF exposure and structural changes in
the developing human brain were also observed: high-
exposed children showed frontal and parietal cortical
thinning with disappearance or even reversal of the typical
sex dimorphism in several cortical areas [10]. In addition,
a positive association between autism spectrum disorders
and prenatal residential proximity to overall organophos-
phates (3rd trimester) and CPF (2nd trimester) has been re-
cently evidenced [11].
Both US and EU regulatory bodies have recently
started a process for reconsideration of reference values
for CPF in order to protect human health. Specifically
the US EPA stated in its preliminary risk assessment that
a coherent mode of action for CPF has not yet been eluci-
dated to explain the effects reported for low dose expos-
ure. In this framework several mechanisms have been
proposed, suggesting that anticholinesterase toxicity might
not be the only key event [12]. A specific neuroendocrine
disruption that encompasses the brain–pituitary complex
has been proposed so far for selected environmental con-
taminants such as bisphenol A, phthalates and polychlori-
nated byphenyls [13,14].
As for CPF, exposure to doses devoid of systemic tox-
icity during development has been shown to affect gen-
eral biological processes such as cell cycle, apoptosis,
DNA synthesis or oxidative stress processes [15,16]. In
the central nervous system (CNS), several in vivo and
in vitro studies evidenced that CPF affects neural cell
replication and differentiation, resulting in immediate
and delayed-onset changes in synaptogenesis, neurotrans-
mitter release, expression of neurotransmitter receptorsand of neuropeptides and their receptors, over and
above the consequence of cholinesterase inhibition
[17-19]. In rats, CPF affects neural systems beyond the
cholinergic one, such as serotonergic and dopaminergic
transmission, in a sex-dimorphic fashion [20]. Develop-
mental CPF exposure causes long-term alterations in
behaviors possibly related to these neural effects such as
changes in cognitive performance in the 16-arm radial
maze or increased risk-taking behavior, affecting both
sexes to a different extent [21,22]. Response to novelty,
anxiety and social behavior repertoire are major targets
of CPF effects in mice [23-25]. In agreement with rat
studies, CPF exposure affected in a different way male
and female mice, and both magnitude and direction of
the effects were dependent on dose and time windows
of administration. Inefficacy of the selective serotonin
re-uptake antagonist fluvoxamine, was observed in male
and female prenatally exposed to CPF [25] substantiat-
ing the hypothesis that serotonergic transmission is tar-
geted by CPF during CNS maturation [21,26]. Notably,
perinatal exposure to CPF also affects the levels of the
hypothalamic neuropeptides oxytocin (OXT) and vaso-
pressin (AVP) in mice [27]. Hypothalamic neuro-peptides
act as key regulators of anxiety, aggression as well as of
various aspects of social behavior in mammals [28-30],
moreover their release in specific brain regions such as
hypothalamus and amygdala has a significant estrogenic
and sex-dimorphic regulation [28,31-34].
In this framework, the consistent findings of alter-
ations in social competencies and anxiety levels after
developmental CPF exposure supports the hypothesis
that CPF may interfere with maturation of sexually
dimorphic neuroendocrine pathways in the develop-
ing CNS, in addition to its recognized cholinergic
toxicity [13].
The goal of the present study was to evaluate the ef-
fects of developmental CPF exposure on social recogni-
tion and on gene expression of different neuroendocrine
markers in hypothalamus and amygdala. To this aim, we
attempted to mimic the most probable human perinatal
exposure scenario by administering dietary CPF from
gestational day 15 to lactation day 14 in CD-1 outbred
female mice. In their offspring we evaluated the long
term effects of such exposure on social recognition in
both sexes at adulthood, analyzing, in parallel, the ex-
pression of estrogen receptor (ER)α, ERβ, Oxt and Avp
genes (as neurophysin I and II precursors, respectively)
as well as of their specific receptors oxytocin receptor
(OxtR) and vasopressin receptor (AvpR)1a in two brain
regions, hypothalamus and amygdala, which have a key
role in neuroendocrine control of affective and social re-
sponses [29].
The effects of this dietary treatment schedule on
acetylcholinesterase (AChE) activity in brain and blood
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[postnatal day (PND) 0 and 14].
Methods
Animals and treatments
All experiments on animals were performed according
to the European Community Council Directive 86/609/
EEC and to Italian Legislation on Animal Experimentation
(Legislative Decree 116/92). Experiments were effectively
carried out according to the Animal Research: Reporting
In Vivo Experiments (ARRIVE) guidelines for reporting
animal studies.
Male and female mice of a Swiss-derived outbred strain
(CD-1, Harlan, S. Pietro al Natisone, Italy), were housed in
polycarbonate breeding cages with a 12–hr light-dark
cycle (light on 20:00-8:00) and with free access to food
and water. Females were inspected daily for the presence
of the vaginal plug (Gestational Day, GD 0). The stud was
removed 10 days after the discovery of the vaginal plug.
On GD 15 females were randomly assigned to one of the
two prenatal treatments [control standard (STD) diet
(DP/1000, Altromin-Rieper, Vandoies-BZ), or CPF diet
(CPF, SIGMA in the proportion of 57.15 mg CPF/kg of
STD diet). This amount of CPF added to the diet corre-
sponds to a dose of 6 mg/kg/bw/day according to a food
consumption of approximately 5 g/day recorded in this
strain of mice. CPF diet was administered to pregnant fe-
males from GD 15 until lactation/ PND 14.
The dose selected is higher than environmentally rele-
vant exposure but lies within the range of doses used in
rodent studies showing delayed neurobehavioral effects
in the offspring in the absence of maternal or systemic
toxicity. Specifically, the diet regimen was based on our
previous studies indicating that the 6 mg/kg/day dose
administered from GD 14 to 17 by oral gavage was safe
with respect to reproductive performance of treated
dams [pregnancy length, number of pups at delivery, sex
ratio], and it does not induce overt toxic symptoms in
dams or major effects on pup’s health parameters such
as weight at delivery and impairment of growing rate
[23]. All females consumed their assigned diets ad libi-
tum and pellets were weighed every other day to esti-
mate the amount of ingested food. As food consumption
increases during the first week of lactation in compari-
son to pregnancy, lactating females assumed higher CPF
levels than those received during pregnancy. However
we maintained during lactation the same diet regimen
administered during pregnancy as a previous study dem-
onstrated that following a regimen similar to the present
one (CPF at a dose of 5 mg/kg/day in the diet through-
out gestation, delivery and lactation) non quantifiable
CPF levels were found in the pups, while the estimate
exposure derived from CPF concentration detected in
the milk was around 0.025 mg/kg/day [35].Sample size for behavioral tests was estimated to allow
the detection of a standardized mean difference (delta
effect size) = 1.2 between CPF and OIL groups, with a
two-sided alpha = 0.05 and a power = 0.80. At these con-
ditions, a minimum of n = 9 mice per group were
needed. In the Open Field test, where male and female
littermates were analyzed, at least 9 couples per treat-
ment group were considered (for a total of ≥ 18 animals
per group).
Twenty litters (10 STD and 10 CPF) were left undis-
turbed till weaning, and at this time males and females
from each litter were caged separately. Animals from
each litter were assigned to experimental procedures fol-
lowing this scheme: one male and one female were
assigned to behavior analysis and one male and one fe-
male from each litter were assigned to neuroendocrine
assessment at adulthood. Slight differences in sample
size between experiments were due to technical problem
during video-recording.
Fourteen (5 STD and 9 CPF) additional dams were
assigned to the assessment of CPF effect on acetylcholin-
esterase (AChE) activity in brain and blood 24 h within
delivery. AChE activity was further assessed on tissue
samples on PND 0 (serum: 6 STD and 8 CPF; brain: 8
STD and 8 CPF) and on PND 14 (serum: 8 STD and 8
CPF; brain: 8 STD and 8 CPF) that were littermates of
subjects undergoing behavioral and neuroendocrine as-
sessments at adulthood.AChE enzymatic analysis
Mouse brains were removed from skull, weighed and
homogenized (1 min) in cold 0.038 M Tris–HCl buffer,
pH 7.6. Blood samples were collected centrifuged
(1000 g at 4°C for 5 min) to separate plasma from red
blood cells. Serum was collected and frozen for subse-
quent analysis.
AChE activity was measured by Ellman’s spectrophoto-
metric method [36-38]: Acetylthiocholine 0.56 mM was
used as substrate and incubation in 0.05 M sodium phos-
phate buffer, pH 7.2 lasted 30 min at 37°C. Aliquots of
brain homogenates (100 μl diluted 1:5 for pups PND 0,
50 μl diluted 1:20 for pups PND 14 and 50 μl diluted 1:10
for females at delivery) were used for enzymatic analyses.
Aliquots of serum (25 μl diluted 1:20 for pups PND 0 and
diluted 1:80 for mothers and pups PND 14) were used for
enzymatic analyses.Behavioral assessment
Males and females of both STD and CPF groups underwent
behavioral testing on PND 70 during the dark phase of the
cycle. Behavioral analysis was performed by observers blind
to the treatment received by each animal.
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Animals underwent a single 20-min open-field test. 10
STD and 9 CPF from each sex were individually placed
in the centre of a black plexiglas open-field arena (40 ×
40 × 40 cm). A videocamera suspended over the arena
was connected to a videotracking system (Ethovision,
Noldus, NL) to record and analyze spontaneous behavior
in the arena. The following variable were considered:
distance moved in the arena to assess locomotor activity
levels; time spent and number of visit in central and per-
ipheral areas to assess preference for safer zone, and
speed. Furthermore, we analyzed the time course of dis-
tance moved by dividing the 20 min total observation in
four 5-min blocks.
Social recognition
Males and females from each diet group underwent a
social recognition test which was administered following
two different protocols according to sex. As for males,
the test consisted of repeated exposure to a con-specific
kept under a small wire cage to prevent direct “aggres-
sive” responses between the two males. As for females,
we selected a direct free interaction protocol, since no
aggressive responses occur during female-female mouse
encounters. Direct free interaction protocols in female
mice have greater resolution power since they allow to
record not only behavioral responses but also ultrasonic
vocalizations (that are elicited in the residential female
by an unfamiliar female) [39-41]. Importantly, from our
previous studies in developmental CPF exposures, we
know that vocalization rates in such female task can be
modified by prenatal CPF exposure [42]. This methodo-
logical choice should maximize the likelihood to detect
effects of the CPF treatment in the two sexes; however it
hinders direct comparisons between male and female
performances because of different length of intertrial in-
tervals (15 vs 45 min) affecting retention performances
and different presentation of social stimuli (wire-caged
male vs free interacting female).
Males
19 male mice (STD n = 9; CPF n = 10) were tested indi-
vidually. The social recognition test took place on 2 days
in a sound attenuated chamber. The social recognition
task was preceded by a habituation session: each experi-
mental subject was introduced for 10 min in the experi-
mental cage enriched with a small round wire cage; after
this period experimental mice underwent the social recog-
nition test: Test (S1) - a stimulus mouse, unfamiliar con-
specific of the same sex and age, was introduced for 5 mi-
nutes inside the home cage enclosed in the small, round
wire cage; Retest same (S2) - after an inter-trial interval of
15 min the S1 stimulus mouse is re-introduced in the home
cage enclosed in the wire cage for 5 min; Retest different(S3) - after an inter-trial interval of 15 min, a novel stimulus
mouse was enclosed in the same wire cage and introduced
in the home cage for 5 min. The entire social recognition
test was videorecorded and later analyzed by an experi-
menter blind to treatment condition of the male “The
Observer”, a software system for collection and analysis
of behavioral data (Noldus, NL). During video-recorded
sessions (S1, S2, S3), the following behavioral responses
were considered (frequency, duration and latency): so-
cial investigation, sniffing the round wire cage and the
stimulus animal; rearing, standing on hind legs; groom-
ing, self-cleaning (wiping, licking, combing or stretching
of any part of the body).
Females
18 female mice (STD n = 9; CPF n = 9) were individually
housed in standard cages for 3 days and thus considered
as resident females. Additional untreated females (n = 3)
(of comparable age and body weight) socially housed
served as test partners. The social recognition test took
place on the following day in a sound attenuated chamber.
Test (S1) - a female partner is introduced in the home
cage of the isolated resident for 3 min and after that
returned to its home cage; Retest Same (S2) - 45 min after
the test, the same female partner is re-introduced in the
home cage of the resident for 3 min; Retest Different
(S3) - 45 min after the Retest Same, a novel partner is
introduced for 3 min in the cage of the resident. For
each resident, partners used in S2 and S3 phases were
never drawn from the same social group to provide the
maximum olfactory novelty during the S3 phase. During
the three experimental phases number of ultrasonic vocal-
izations (USVs) was assessed using a ultrasonic micro-
phone (Avisoft UltraSound-Gate condenser microphone
capsule CM16, Avisoft Bioacoustics, Germany) sensitive
to frequencies between 10-180 kHz and suspended 10 cm
above the cage. Vocalizations were recorded using an Avi-
soft Recorder (Version 3.2). Settings included sampling
rate at 250 kHz; format 16 bit. For acoustical analysis, re-
cordings were transferred to Avisoft SASLab Pro (Version
4.40) and a fast Fourier transformation (FFT) was con-
ducted. Spectrograms were generated with an FFT-length
of 512 points and a time window overlap of 75% (100%
Frame, Hamming window). The spectrogram was pro-
duced at a frequency resolution of 488 Hz and a time
resolution of 1 ms. A lower cut-off frequency of 15 kHz
was used to reduce background noise outside the relevant
frequency band to 0 dB. Call detection was provided by an
automatic threshold-based algorithm and a hold-time
mechanism (hold time: 0.005 s). An experienced user
checked the accuracy of call detection, and obtained a
100% concordance between automated and observational
detection. The broad range for USV recording allowed de-
tecting all USVs emitted but did not provide information
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titive versus aversive meaning). During the test, the 3 min
female–female encounters were also recorded by a video-
camera placed 12 cm far from the cage. Videotapes were
later analyzed by an experimenter blind to treatment
condition of the resident females using “The Observer”,
a software system for collection and analysis of behav-
ioral data (Noldus, Wageningen 6700 AG, 177 The
Netherlands). During video-recorded sessions (S1, S2,
S3), frequency and duration of the following behavioral
responses emitted by the resident female were collected: –
exploring: moving around the cage, sniffing the physical
environment, rearing; – social investigation: sniffing
any part of the partner’s body; – grooming: self-
cleaning (licking, combing and stretching any part of
its own body).
Neuroendocrine assessment
On PND 70, behaviorally-naïve littermates of mice under-
going behavioral assessment were sacrificed and brain dis-
sected (STD n = 5; CPF n = 5 for each sex). Brains were
removed from skulls and ventral surface was exposed and
hypothalamus removed. Amygdala nuclei were removed
from a brain slice (3 mm tick, fifth-eighth coronal chan-
nel) obtained by a rodent brain matrix for adult mice (ASI
Instruments, RBM 2000C, MI, USA). Hypothalami and
amygdalae were flash frozen in liquid nitrogen and stored
at -80°C until use. Following homogenization by the
Miccra D-1 homogenizer (ARTmoderne Labortechnik,
Müllheim, Germany), total RNA was extracted using
the RNAeasy Mini Kit (QIAGEN, Hilden, Germany).
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ESR1 (ERα) NM_007956.4 fw
rev
ESR2 (ERβ) NM_207707.1 fw
revWilmington, DE, USA) whereas integrity was evaluated
by a 1% agarose gel electrophoresis. One μg of total
RNA from each sample was retrotranscribed to cDNA
using the cDNA Synthesis Kit (Quantace, London, UK).
Specific primers for Oxt (Neurophysin I OXT carrier
protein), Avp (Neurophysin II AVP carrier protein),
OxtR, AvpR1A, ERα, ERβ, as well as for glyceraldehyde-
3-phosphate dehydrogenase (Gapdh) and β-actin (Actb),
as reference genes, were designed using the Primer-
BLAST web application (www.ncbi.nlm.nih.gov/tools/
primer-blast) and purchased from Invitrogen (Life
Technologies, Paisley, UK). Primers sequences are listed
in Table 1. The SensiMix Plus SYBR (Quantace) was
used to perform Real-time PCR assays running reac-
tions on a Stratagene MX5005P thermocycler instru-
ment. Experiments were performed in duplicate on 96
well PCR plates. The thermal program was as follows:
1 cycle at 94 for 10 minutes; 40 cycles at 94°C for 10 sec-
onds, 58°C for 10 seconds and 72°C for 10 seconds; 1
dissociation cycle from 55 to 94°C to verify amplifica-
tion products. Evaluation of Gapdh and Actb stability
was performed with BestKeeper [43]. In hypothalamus
the two reference genes were highly correlated among
each other (Pearson coefficient r = 0.930; p-value =
0.001) and the calculated BestKeeper index presented a
standard deviation (SD) = 0.90. By contrast, in amygdala,
the BestKeeper index had a SD = 1.2 with a lower correl-
ation between Gapdh and Actb (r = 0.727; p-value =
0.001). Since Actb had the lower SD (0.65 vs 0.91 for
Gapdh), only this one was used as reference gene in
both tissues to calculate mean relative expression
values + SEM.CR

















Table 2 AChE activity following developmental CPF
exposure
Standard Diet CPF
Dams Day of delivery Serum 5689 ± 1268 1159 ± 240 (**)
Brain 14547 ± 437 14311 ± 1172
Pups PND 0 Serum 1713 464 1629 377
Brain 1671 ± 162 1789 ± 175
PND 14 Serum 7170 ± 561 6445 ± 300
Brain 14869 ± 1074 15537 ± 1188
Data are mean value (nmol/min/gr of tissue) ± standard deviation; PND
postnatal day; (**) p <0.01 following T-test.
Venerosi et al. Environmental Health  (2015) 14:32 Page 6 of 10Statistical analysis
Normality distribution of data was evaluated by means
of Shapiro-Wilk test; homogeneity of variance was
assessed by means of Levene Test; Greenhouse-Geisser
correction was applied to take into account potential
violation of the assumption of Compound Symmetry/
Sphericity in the case of repeated measures analyses.
AChE data were analyzed by unpaired Student’s t-Test.
On open field data, analysis of variance (ANOVA) in-
cluded prenatal treatment (2 levels) as between-litter
fixed factor, sex as within-litter factor and 5 min-block
as repeated measures (4 levels). As for social recognition
test the model of analysis applied in each sex included
prenatal treatment (2 levels) as between-subject fixed
factor, and session as repeated measures (3 levels). Post-
hoc comparisons were performed using Tukey’s test,
which can be applied also in the absence of significant
ANOVA results [44].
Due to the low sample size, data on gene expression
were analyzed by Kruskal-Wallis ANOVA, comparing
the four subgroups (CPF males, CPF females, OIL males,
and OIL females) with respect to each brain area separ-
ately. Chi-square partitioning of the overall Kruskal-
Wallis chi-square was then performed to assess main ef-
fects of treatment (2 levels, 1 degree of freedom, df) and
sex (2 levels, 1 df), and their interaction (1df ). Posthoc
Mann-Whitney tests were performed in case of signifi-
cant interactions.Results
Reproductive performance and AChE activity
Confirming our previous data, analysis of body weight
data, litter size and sex ratio did not show any significant
effects of CPF supplemented diet on the offspring (data
not shown).
When measured on the day of delivery, dietary CPF
exposure induced 80% inhibition of serum AChE in the
dams (T test p < 0.01) but not of brain AChE. As for the
offspring, only a significant but very slight inhibition
(about 10%) was found at PND 14 for blood AChE,
while no CPF effects was found for brain AChE either at
birth or at PND 14 (see Table 2).Open field
Developmental exposure to CPF did not affect spontan-
eous behavior in the open field arena. No significant dif-
ferences between STD and CPF mice were found either
on total distance moved or on time spent in the central
area (an index of anxiety). Habituation profile was evi-
dent in all animals [F (3, 51) = 38.27 p < 0.01] and not af-
fected by CPF exposure. Only a main effect of sex was
found [F (1, 17) = 0.021 p < 0.01], indicating a higher
level of locomotion in females (see Figure 1).Social recognition
Males
CPF male mice showed higher social investigation (total
sniffing) in each session of the test than STD mice [F (1,
17) = 8.42 p = 0.001]. As expected in the third session of
the social recognition test both CPF and STD showed
a renewal of interest towards the unfamiliar mouse
[F (2, 34) = 12.78 p < 0.001] (see Figure 2A).
Females
As for social investigation duration, a main effect of CPF
[F (1, 15) = 5.93 p = 0.028] and a treatment x session inter-
actions [F (2, 30) = 3.79 p = 0.034] were observed. CPF fe-
males showed increased social investigation only during
the second exposure to the same partner (S2) (p < 0.01,
after post hoc comparisons) (Figure 2B) and did not show
enhancement of social investigation of the novel partner
during S3. USV emission, normally emitted during a
female-female social encounter in a resident-intruder
paradigm [41], follows exactly the same profile of social
investigation throughout the three sessions of the test.
Expression of neuroendocrine markers in Hypotalamus
and Amygdala Hypothalamus
No differences between CPF and controls were evident
for mRNA expression of Oxt, OxtR, Avp, AvpR1a, and ERα.
By contrast, ERβ was significantly increased only in CPF
exposed males (see Figure 2) [sex x treatment interaction
Chi-Square (1) = 6.2960, p = 0.0121; Mann-Whitney test
CPF males vs STD males p = 0.02 ]. For Avp (neurophysin
II) expression, only a main effect of sex [Chi-Square (1)
=8.652 p = 0.03] was detected.
Amygdala
In the amygdala, CPF significantly decreased level of Oxt
expression in males [sex x treatment interaction Chi-
Square (1) = 7.,0003, p = 0.0081; Mann-Whitney test CPF
males vs STD males p = 0.02]. A CPF-induced increase
was found for AvpR1a expression in both sexes [main ef-




Figure 1 Long-term behavioral effects of developmental exposure to CPF. A) Open field test on PND 70. Upper panel: Total distance
moved throughout the 20 min: both sexes and both treatments showed the expected progressive decrease of locomotor activity. Lower panel:
Time spent in the central area of the arena (an index of anxiety); data are mean values + SEM, (STD: n = 10; CPF: n = 9 in each sex group. B) Male
social recognition test. CPF males showed a significant higher level of social investigation (total sniffing) towards mouse partners than STD mice.
S1 session 1 (5-min exposure to a partner; S2 session 2 (5-min exposure to the same partner ); S3 session 3 (5-min exposure to a novel partner).
Sessions are spaced by a 15-min intertrial interval (ITI). Data are mean values + SEM, (STD: n = 9; CPF: n = 9); C) Female social recognition test.
Larger graph: CPF females show increased social investigation (total sniffing) only during S2. Smaller graph: number of ultrasonic vocalizations
(USVs) emitted by the resident female during the test, showing a profile across sessions comparable to sniffing response. S1 session 1 (3-min
exposure to a partner); S2 session 2 (3-min exposure to the same partner); S3 session 3 (3-min exposure to a novel partner). Sessions are spaced



























































































Figure 2 Gene expression (mRNA levels) of neuroendocrine markers in hypotalamus (upper panel) and amygdala (lower panel) at PND
70. Oxt neurophysin I, oxitocin; Avp neurophysin II, vasopressin; ERβ Estrogen Receptor beta; ERα Estrogen Receptor alpha; OxtR oxytocin receptor;
AvpR1a, Vasopressin receptor 1a; * p < 0.05; ($$) main effect of CPF treatment p < 0.01. Data are expressed as relative expression values (Actb as
reference gene) + SEM.
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In the absence of brain AChE inhibition, dietary CPF ex-
posure throughout pregnancy and lactation modifies so-
cial behavior patterns and mRNA expression of
underlying neuroendocrine markers in the adult off-
spring. Notably, CPF effects are different in the two
sexes, with males more affected than females.
Behavioral responses in the two sexes cannot be dir-
ectly compared in the present study, due to the different
task (as well as different inter trial interval durations)
applied. However it is noteworthy that CPF males are af-
fected throughout all the sessions of the social recogni-
tion test, an effect more evident during the first two
session of the test. CPF enhanced social response also in
females, but with a different pattern: enhanced response
was evident only during the second exposure to the
same partner (just when habituation, i.e. a decrease,
would be expected), a peculiar profile confirmed by USV
emission rates. These behavioral data confirm the results
of the prenatal or neonatal exposure protocols where
CPF treatment induced enhanced response towards so-
cial salient stimuli (e.g. enhancement of aggressive be-
havior observed in adolescent males and of social and
maternal responsiveness in females, [23,42]). Thus al-
tered responsiveness to social cues appears as a hallmark
of developmental exposure to CPF in mice, regardless
exposure window selected.
As for neuroendocrine markers, both hypothalamus
and amygdala appear as sensitive target areas for CPF
exposure: as for males, CPF increased levels of ERβ ex-
pression in hypothalamus and decreased Oxt expression
in amygdala; CPF also increased AvpR1a expression in
amygdala in both sexes.
The sex- and region-specific effects of developmental
CPF on ERβ are suggestive of mechanistic hypothesis to
be further explored. The observation that CPF signifi-
cantly induced ERβ expression in the hypothalamus and
not in the amygdala suggests that CPF does not act as a
general estrogen-like compound globally up-regulating
ERβ. The selective CPF effect on ERβ in the absence of
effect on ERα, could be explained by the existence of dif-
ferent ontogenetic expression patterns of ERα/ERβ tran-
scripts [45,46]. Similar mechanisms could be responsible
for the sexual dimorphic CPF effects, also considering
the morphogenetic role of estrogen and ERβ in sexual
differentiation and development of the brain [47].
CPF also impacts on Oxt and AvpR1a expression in
amygdala. This interference has to be interpreted to-
gether with behavioral results. Of note the enhanced in-
vestigative responses to unfamiliar social stimuli
observed in CPF-exposed mice (more evident in males)
is associated with a decrease of Oxt expression in amyg-
dala in males. Intriguingly, the behavioral profile of mice
carrying deletion of the Oxt gene [28] also displayimpairments in habituation to a familiar partner whereas
lack of ERβ gene had no consequences on social recog-
nition in either male or female mice [48].
All together, these data confirm our previous hypoth-
esis that exposure to CPF leads to inappropriate process-
ing of the salience of diverse social cues [49]. Such
hypothesis also fits well with the growing body of evi-
dence from animal and human studies that implicates
amygdalar OXT in the emotional processing of social
stimuli and activation of the appropriate response (i.e.
affiliation or aggression) [50,51], indeed, our data sup-
port the idea that amygdalar Oxt and AvpR1a upregula-
tion represents the focal CPF-induced change underlying
behavioral alterations.
This is the first in vivo study exploring potential ad-
verse effects of CPF on molecular endpoints in amyg-
dala. Future studies should focus on the links between
the pattern of neuroendocrine effects observed in amyg-
dala with selected downstream pathways known to be
modulated by hypothalamic neuropeptides [52] and in-
volved in the modulation of either the reward or the
affective value of social cues. Those links likely involve
neurotransmitter systems targeted by prenatal CPF, in-
cluding serotonin [20,25,53,54] noradrenaline and dopa-
mine [55,56].
A limited number of evidence is so far available ex-
ploring the endocrine disrupting potential of CPF,
primarily exploring in vitro methods. CPF alters
gonadotropin-releasing hormone biosynthesis in GT1-7
hypothalamic cell lines [57]; both anti-androgenic [58]
and estrogenic effects, inducing growth in breast cancer
cells [59,60], have been observed. Interestingly, still
in vitro data from a wide screening study using cancer
fibroblast cells (MCF-7BUS) evidenced that CPF select-
ively increases ERβ, but not ERα gene expression [61].
Our study confirms for the first time in vivo that ERβ is
a target of CPF endocrine disrupting activity.
Interestingly, data from AChE in dams (actually receiving
the CPF supplemented diet only for five days, during late
pregnancy) show that opposite to a 80% reduction of serum
AChE activity, no reduction of brain AChE activity was de-
tected. These data partially confirm the order of magnitude
of inhibition “ plasma > RBC > brain” developed by the
PBPK/PD model developed for CPF in rat and humans,
with inhibition of brain AChE occurring only at doses of 10
mg/Kg or higher [62]. Other rat data indicate marked brain
AChE inhibition following CPF dietary exposure in adult
rats, but only after chronic dietary exposures (e.g. 21
weeks [63]; 6-12 months [64]).
Conclusions
The route of exposure selected in our study corresponds
to relevant human exposure scenarios since it assures
continuous levels of exposure from pregnancy to
Venerosi et al. Environmental Health  (2015) 14:32 Page 9 of 10lactation. It is worth noting that, at variance from previ-
ous findings showing small but significant brain AChE
inhibition in the offspring 4 and 24 hrs following admin-
istration of CPF [65], we did not find any evidence of
brain AChE inhibition either at birth and at day 14 in
the offspring. Thus, our findings support the view that
mechanisms underlying developmental neurotoxicity of
CPF are more complex and possibly independent from
its anticholinergic activity.
Whereas it is clear that AChE inhibition is not the
most sensitive endpoint, the spectrum of effects reported
in vitro, in animal models and in humans coherently
supports that endocrine effects, especially in susceptible
time windows, should deserve more attention in the risk
assessment of OP insecticides for a twofold reason. On
one side, CPF neuroendocrine effects on Oxt and
AvpR1a are extremely relevant since these pathways are
implicated in several affective and emotional behaviors
extending to psychopathology [29]. On the other, early
alteration of physiological ERβ expression pattern could
be associated with specific prenatal/perinatal morpho-
genetic pathways (e.g. in ERβ -/- mice abnormal migration
of cortical neurons to upper laminae leads to permanent
alteration in cortical organization [66,67]) which could
have permanent consequences on brain development and
functions, in line with child cohort studies reporting struc-
tural changes in developing brains [10].
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